Get started
Work

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Year: 2016
Type: article
Study design: Clinical Trial
DOI: 10.1038/bmt.2016.322
Authors: B S Andersson, P F Thall, B C Valdez, D R Milton, G Al-Atrash, J Chen, A Gulbis, D Chu, C Martinez, S Parmar, U Popat, Y Nieto, P Kebriaei, A Alousi, M de Lima, G Rondon, Q H Meng, A Myers, J Kawedia, L L Worth, M Fernandez-Vina, T Madden, E J Shpall, R B Jones, R E Champlin
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
Funders: University of Southern California, Otsuka America Pharmaceutical, Otsuka America, Otsuka Pharmaceutical, National Cancer Institute, National Center for Advancing Translational Sciences
OpenAlex ID: W2564896331
FWCI: 3.957
Cites: 62
Cited by: 85
Related to: 10